ASMB Assembly Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ASMB

Price (delayed)

$0.98

Market cap

$51.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.82

Enterprise value

$10.22M

Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the ...

Highlights
The company's debt has shrunk by 54% YoY and by 24% QoQ
ASMB's EPS is up by 35% year-on-year and by 5% since the previous quarter
ASMB's quick ratio is down by 36% year-on-year but it is up by 30% since the previous quarter
Assembly Biosciences's revenue has shrunk by 100% YoY
ASMB's gross profit has shrunk by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.assemblybio.com
Peers: IRWD ENZN CPIX CPRX

Key stats

What are the main financial stats of ASMB
Market
Shares outstanding
52.12M
Market cap
$51.08M
Enterprise value
$10.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.72
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$88.95M
EBITDA
-$88.45M
Free cash flow
-$80.49M
Per share
EPS
-$1.82
Free cash flow per share
-$1.58
Book value per share
$1.35
Revenue per share
$0
TBVPS
$1.63
Balance sheet
Total assets
$83.12M
Total liabilities
$12.78M
Debt
$2.63M
Equity
$70.33M
Working capital
$69.77M
Liquidity
Debt to equity
0.04
Current ratio
8
Quick ratio
7.4
Net debt/EBITDA
0.46
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-79.1%
Return on equity
-93.8%
Return on invested capital
-165.5%
Return on capital employed
-121.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ASMB stock price

How has the Assembly Biosciences stock price performed over time
Intraday
0.82%
1 week
-5.77%
1 month
-0.71%
1 year
-44%
YTD
-24.62%
QTD
16.61%

Financial performance

How have Assembly Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$90.51M
Net income
-$88.95M
Gross margin
N/A
Net margin
N/A
Assembly Biosciences's revenue has shrunk by 100% YoY
ASMB's gross profit has shrunk by 100% YoY
Assembly Biosciences's operating income has increased by 30% YoY and by 3.8% QoQ
Assembly Biosciences's net income has increased by 29% YoY and by 4.4% QoQ

Growth

What is Assembly Biosciences's growth rate over time

Valuation

What is Assembly Biosciences stock price valuation
P/E
N/A
P/B
0.72
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ASMB's EPS is up by 35% year-on-year and by 5% since the previous quarter
The price to book (P/B) is 62% lower than the 5-year quarterly average of 1.9 but 2.9% higher than the last 4 quarters average of 0.7
The equity has plunged by 52% YoY and by 15% from the previous quarter
Assembly Biosciences's revenue has shrunk by 100% YoY

Efficiency

How efficient is Assembly Biosciences business performance
The ROIC has plunged by 70% YoY and by 29% from the previous quarter
The return on equity has declined by 44% year-on-year and by 15% since the previous quarter
The company's return on assets fell by 36% YoY and by 13% QoQ

Dividends

What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASMB.

Financial health

How did Assembly Biosciences financials performed over time
The total assets has contracted by 49% YoY and by 18% from the previous quarter
ASMB's quick ratio is down by 36% year-on-year but it is up by 30% since the previous quarter
The company's debt is 96% lower than its equity
The company's debt has shrunk by 54% YoY and by 24% QoQ
The equity has plunged by 52% YoY and by 15% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.